Newswise — There are about 100 billion neurons in an adult human brain. We’ve long known they don’t all look the same. We also know they don’t behave the same. But we’re still trying to find out just how many different types of neurons there are and what they do. To be able to do this at scale, scientists are turning to molecular methods.
Now, a team from the Salk Institute for Biological Studies and the University of California San Diego has, for the first time, profiled chemical modifications in the DNA of individual neurons, giving the most detailed information yet on what makes one brain cell different from its neighbor.
Published in Science, the study analyzed a neuron’s methylome, or pattern of methylated DNA. DNA methylation is chemical addition of methyl groups to the bases in a DNA molecule, which alters how genes are expressed without changing their sequence. These are epigenetic changes, and cataloging them, in a total of about 6,000 cells or 1 trillion DNA bases, enabled the team to sort the neurons into subtypes and create new kinds of brain maps based on a neuron’s gene expression. The study also identifies new subtypes of neurons.
The paper’s senior co-authors are Joseph Ecker, director of Salk's Genomic Analysis Laboratory and an investigator of the Howard Hughes Medical Institute, Margarita Behrens, senior staff scientist at Salk, and Eran Mukamel of the UC San Diego Department of Cognitive Science. The first authors are Chongyuan Luo, a Salk research associate, and Christopher Keown, a cognitive science graduate student at UC San Diego.
The coauthors believe their paper makes important advances both in molecular biology and in computation.
“Our research shows that we can clearly define neuronal types based on their methylomes,” said Behrens. “This opens up the possibility of understanding what makes two neurons – that sit in the same brain region and otherwise look similar – behave differently.”
Mukamel, assistant professor of cognitive science and head of the Computational Neural Data and Dynamics Lab at UC San Diego said, “Our study represents a completely different way to look at the diversity of brain cell types. The innovation of the paper is that we were able to prepare DNA libraries from individual neurons and at scale. It is a bit like taking a census but of gene expression, surveying thousands of cells.”
Earlier single-cell methods have focused on analysis of RNA. But levels of RNA can change with conditions, while methylomes are generally stable throughout adulthood. Methylomes, the researchers hypothesize, offer a more precise way to identify neurons.
The team studied neurons in both a mouse and a human. They used a single-cell methylome sequencing method they’d recently developed, applying it to 3,377 neurons from the frontal cortex of a young adult mouse and 2,784 from the frontal cortex of a deceased human male aged 25. Unlike other cells in the body, neurons have two types of methylation, so the team’s approach mapped both types.
Neurons from the mouse frontal cortex, they found, clustered into 16 subtypes based on methylation patterns, while neurons from the human frontal cortex were more diverse and formed 21 subtypes. The methylation patterns of inhibitory neurons – those that provide the brain’s “stop” signals – were more alike between mice and humans than those of the excitatory (or “go”) neurons. This suggests greater evolutionary conservation of inhibitory neurons and might be a clue to their importance. The study also defines new subtypes of human neurons.
“We think it’s pretty striking,” said Ecker, “that we can tease apart a brain into individual cells, sequence their methylomes, and identify many new cell types along with their gene regulatory elements, the genetic switches that make these neurons distinct from each other.”
The team’s results add to the “brain atlas in an objective, data-driven way,” said Mukamel, who is also an affiliate of the Kavli Institute for Brain and Mind at UC San Diego. And that could lead to better understanding not only of the differences between the brains of humans and other animals but also to better understanding of brain development and dysfunction.
The current research follows an earlier paper published in Science, led by Behrens and Ecker with Mukamel as one of the first authors, on epigenetic changes in the developing brain.
Next steps for the work include studying more mice and more humans, as well as comparing methylomes in the brain cells of healthy individuals to those suffering from brain diseases. The coauthors explain that their approach allows them to see differences in neurons that were invisible before.
“If there’s a defect in just one percent of cells, we should be able to see it with this method,” Ecker said, “Until now, we would have had no chance of picking something up in that small a percentage of cells.”
Other researchers on the current study were Jingtian Zhou, Yupeng He, Rosa Castanon, Jacinta Lucero, Joseph Nery, Justin Sandoval, Brian Bui, and Terrence Sejnowski of the Salk Institute; Junhao Li of UC San Diego; and Laurie Kurihara and Timothy Harkins of Swift Biosciences Inc.
The work and the researchers involved were supported by grants from the NIH BRAIN Initiative (5U01MH105985 and 1R21MH112161), the Howard Hughes Medical Institute, and the National Institutes of Health (2T32MH020002).
More information in Science (“Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex,” DOI: 10.1126/science.aan3351) and on the project website, http://brainome.org.